Feature | May 15, 2017

Expert Consensus on MRI and Radiation Exposure in Patients With Implantable Cardiac Electronic Devices

At Heart Rhythm 2017, a panel of experts from 11 international organizations share recommendations for health care providers and patient populations exposed to MRI and radiation

HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices

May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States on indications of patients who undergo magnetic resonance imaging (MRI) and radiation exposure with cardiovascular implantable electronic devices (CIEDs). The expert writing group presented the recommendations included in the “2017 HRS Expert Consensus Statement on Magnetic Resonance Imaging and Radiation Exposure in Patients with Cardiovascular Implantable Electronic Devices” at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.

There is an increasing number of people with CIEDs, and approximately 200,000 pacemakers are implanted in the United States each year.[1] Historically, MRI scanning and radiation exposure for patients with CIEDs has prompted concerns due to their unpredictable effects and interferences in safely and the overall function of the devices. Recent studies have suggested that MRI can be done safely in many patients with magnetic resonance (MR) conditional and nonconditional systems.

The expert consensus statement is intended to help frontline cardiologists, radiologists, radiation oncologists, and other health care professionals involved in the care of adult and pediatric patients with CIEDs. To further address the issue, the expert writing group also discusses the safety of employees with CIEDs who may come into an MRI environment. 

The document provides guidance on who would be suitable to undergo certain procedures and how to monitor the individuals who are exposed to:
• MRI
• Radiation exposure for CT scans
• Cancer treatment with radiation

“Oftentimes, healthcare providers may recommend removing a device before being exposed to radiation for cancer treatments because of existing safety concerns, but the removal of the device itself could pose risks to the patient,” says Julia Indik, M.D., Ph.D., professor of medicine and director of cardiovascular disease fellowship program at the University of Arizona, Sarver Heart Center. “We hope that our recommendations will make decisions easier for clinicians and ensure we are delivering optimal patient care while setting the first-ever standard of individualized protocols for patients with these devices.”

Access the full consensus statement document 

The statement includes specific recommendations in the following subsections:
• Introduction and Methodology
• Definitions of CIED Systems in Relation to MRI
• MRI Technology and Relationship to Risk
• MR Conditional CIED Technology
• Management of the CIED Patient Referred for MRI
• Management of the CIED Patient Undergoing CT Imaging
• Management of the CIED Patient Undergoing Radiation Therapy
• Future Directions

The members of the expert writing group performed a comprehensive electronic literature search and then developed a series of recommendations. This was done from randomized controlled trials, nonrandomized observational studies, and case series to support useful and practical recommendations, given that each individual institution serves its patient population uniquely. The writing group also evaluated computational modeling and in vitro and animal studies to explore and identify specific combinations that may pose a higher risk to patients, which cannot be determined by clinical studies alone.

The expert consensus statement was developed in collaboration with 11 international organizations: American Heart Association (AHA), American College of Cardiology (ACC), American College of Radiology (ACR), Asia Pacific Heart Rhythm Society (APHRS), American Society for Radiation Oncology (ASTRO), Council of Affiliated Regional Radiation Oncology Societies (CARROS), European Heart Rhythm Association (EHRA), Japanese Heart Rhythm Society (JHRS), Pediatric and Congenital Electrophysiology Society (PACES), Sociedade Brasileira de Arritmias Cardíacas (SOBRAC), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).

The document was also published today in the online edition of HeartRhythm, the official journal of the Heart Rhythm Society. To review the full document, click here.
 

For more information: www.hrssessions.org

 

Reference:

1. Van Der Zee SA, Doshi SK. Permanent leadless cardiac pacing. Available at http://www.acc.org/latest-in-cardiology/articles/2016/03/23/08/09/permanent-leadless-cardiac-pacing.


Related Content

News | Cardiac Imaging

On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows ...

Home February 22, 2024
Home
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Home February 12, 2024
Home
News | Cardiac Imaging

November 16, 2023 — Cardiovascular diseases rank among the top causes of death across the world, and cardiac ...

Home November 16, 2023
Home
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Home September 21, 2023
Home
News | Cardiac Imaging

July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s ...

Home July 11, 2023
Home
Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

Home July 10, 2023
Home
News | Cardiac Imaging

June 29, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home June 29, 2023
Home
News | Cardiac Imaging

June 26, 2023 — Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited ...

Home June 26, 2023
Home
News | Cardiac Imaging

June 15, 2023 — Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and ...

Home June 15, 2023
Home
News | Cardiac Imaging

June 9, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home June 09, 2023
Home
Subscribe Now